{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:59:03Z","timestamp":1775804343238,"version":"3.50.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to analyze the clinical characteristics and rate of transfusion related adverse reactions (TRARs) in pediatric patients with malignant solid and hematological tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      A retrospective analysis was conducted on 34,195 blood transfusions (RBC: 41.0%; PLT: 40.7%; FFP: 16.0%; cryoprecipitate: 2.3%) among 9,129 pediatric patients. TRARs were classified and severity graded according to the Chinese Haemovigilance Network criteria. Statistical comparisons were made between serious (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200937) and non-serious (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009194) TRAR cases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The overall TRAR rate was 680\/100,000 (231\/34,195), with PLT-associated TRARs being most frequent (1,250\/100,000, 174\/13,915). Allergic transfusion reactions (ATRs) dominated (95.7%, 221\/231), followed by febrile non-hemolytic reactions (FNHTRs, 3.5%, 8\/231). Serious TRARs (16.0%, 37\/231) primarily involved ATRs (91.9%, 34\/37), presenting with respiratory\/gastrointestinal symptoms (41.2%) or anaphylactic shock (14.7%). After adjustment for multiple comparisons using the Bonferroni correction, prophylactic premedication was significantly associated with the occurrence of serious TRARs (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Pediatric patients with malignant solid and hematological tumors exhibit a high TRAR incidence, particularly with PLT transfusions. ATRs constitute the majority, underscoring the need for vigilant monitoring and evidence-based prophylaxis. The inefficacy of routine premedication raises important questions about tailored transfusion strategies. Further research is warranted to optimize platelet product selection and TRAR management protocols in this vulnerable population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1724454","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:03:46Z","timestamp":1775801026000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A single center experience of transfusion related adverse reaction in pediatric patients with malignant solid and hematological tumors"],"prefix":"10.3389","volume":"14","author":[{"given":"Gan","family":"Shan","sequence":"first","affiliation":[{"name":"Department of Blood Transfusion, Wuhan Children\u2019s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Ping","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion, Wuhan Children\u2019s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion, Wuhan Children\u2019s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liuchun","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion, Wuhan Children\u2019s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion, Wuhan Children\u2019s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Hongbing","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion, Wuhan Children\u2019s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duan","family":"Ling","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion, Wuhan Children\u2019s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.tracli.2018.08.158","article-title":"How clinicians can minimize transfusion-related adverse events?","volume":"25","author":"Aubron","year":"2018","journal-title":"Transfus Clin Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1056\/NEJMra1802338","article-title":"Hemolytic transfusion reactions","volume":"381","author":"Panch","year":"2019","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1016\/S0140-6736(15)01313-6","article-title":"Transfusion reactions: prevention, diagnosis, and treatment","volume":"388","author":"Delaney","year":"2016","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/trf.16362","article-title":"Transfusion-related adverse reactions: data from the national healthcare safety network hemovigilance module - United States, 2013-2018","volume":"61","author":"Kracalik","year":"2021","journal-title":"Transfusion"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/vox.13291","article-title":"Development of the Chinese haemovigilance network and reporting of adverse transfusion reactions from 2018 to 2020","volume":"117","author":"Tian","year":"2022","journal-title":"Vox Sang"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e29842","DOI":"10.1002\/pbc.29842","article-title":"Comparison of transfusion reactions in children and adults: a systematic review and meta-analysis","volume":"69","author":"Wang","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tracli.2019.08.002","article-title":"Adverse transfusion reactions in transfused children","volume":"26","author":"Moncharmont","year":"2019","journal-title":"Transfus Clin Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1537-2995.2007.01484.x","article-title":"Blood transfusions in children: a multi-institutional analysis of practices and complications","volume":"48","author":"Slonim","year":"2008","journal-title":"Transfusion"},{"key":"B9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/trf.14359","article-title":"Analysis of pediatric adverse reactions to transfusions","volume":"58","author":"Vossoughi","year":"2018","journal-title":"Transfusion"},{"key":"B10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jped.2012.12.009","article-title":"Blood transfusion reactions in children: associated factors","volume":"89","author":"Pedrosa","year":"2013","journal-title":"J Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/0113892029319425240813074610","article-title":"High-throughput sequencing reveals that BCR and TCR repertoires as potential prognostic biomarkers for pediatric patients with B-ALL","volume":"26","author":"Li","year":"2025","journal-title":"Curr Genomics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/0109298665267989231024064200","article-title":"Physiological and pathological roles of NTSR2 in several organs and diseases (review)","volume":"31","author":"Yang","year":"2024","journal-title":"Protein Pept Lett"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2174\/0115665232413510250904105956","article-title":"Advances in gene therapy clinical trials for hemophilia care","author":"Rana","year":"2025","journal-title":"Curr Gene Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"103685","DOI":"10.1016\/j.transci.2023.103685","article-title":"Hematological toxicities of immune checkpoint inhibitors and the impact of blood transfusion and its microbiome on therapeutic efficacy and recipient\u2019s safety and survival outcome: a systematic narrative appraisal of where we are now!","volume":"62","author":"Shouman","year":"2023","journal-title":"Transfus Apher Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.21037\/apm-22-691","article-title":"Supportive care and symptom management in patients with advanced hematological malignancies: a literature review","volume":"11","author":"Chan","year":"2022","journal-title":"Ann Palliat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/j.1537-2995.2006.00995.x","article-title":"Acute transfusion reactions in the pediatric intensive care unit","volume":"46","author":"Gauvin","year":"2006","journal-title":"Transfusion"},{"key":"B17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/trf.12827","article-title":"Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products","volume":"55","author":"Oakley","year":"2015","journal-title":"Transfusion"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1542\/hpeds.2020-005173","article-title":"A single-center description of pediatric transfusion reactions and preventable patient harm","volume":"11","author":"Johns","year":"2021","journal-title":"Hosp Pediatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/trf.16855","article-title":"Relationship between allergic transfusion reactions and allergic predisposition among pediatric patients with hematological\/oncological disease","volume":"62","author":"Yanagisawa","year":"2022","journal-title":"Transfusion"},{"key":"B20","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/trf.16816","article-title":"Changes in the incidence of transfusion reactions in hematological patients over the past 30 years","volume":"62","author":"Bojanic","year":"2022","journal-title":"Transfusion"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1182\/blood-2018-10-833988","article-title":"Noninfectious transfusion-associated adverse events and their mitigation strategies","volume":"133","author":"Goel","year":"2019","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.2450\/2022.0178-22","article-title":"Dissecting the complexity of pediatric blood transfusions and risk of adverse reactions in Aotearoa New Zealand","volume":"21","author":"Wei","year":"2023","journal-title":"Blood Transfus"},{"key":"B23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4103\/0973-6247.214348","article-title":"Transfusion-related adverse reactions in pediatric and surgical patients at a tertiary care teaching hospital in India","volume":"11","author":"Ghataliya","year":"2017","journal-title":"Asian J Transfus Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/vox.12833","article-title":"Analysis of clinical presentations of allergic transfusion reactions and febrile non-haemolytic transfusion reactions in paediatric patients","volume":"114","author":"Yanagisawa","year":"2019","journal-title":"Vox Sang"},{"key":"B25","doi-asserted-by":"publisher","first-page":"151137","DOI":"10.1016\/j.soncn.2021.151137","article-title":"Identifying and understanding transfusion reactions in the oncology population","volume":"37","author":"Graham","year":"2021","journal-title":"Semin Oncol Nurs"},{"key":"B26","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/trf.12918","article-title":"Transfusion-related adverse reactions reported to the national healthcare safety network hemovigilance module, United States, 2010 to 2012","volume":"55","author":"Harvey","year":"2015","journal-title":"Transfusion"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/trf.13475","article-title":"Apheresis platelets are more frequently associated with adverse reactions than pooled platelets both in recipients and in donors: a study from French hemovigilance data","volume":"56","author":"Daurat","year":"2016","journal-title":"Transfusion"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1213\/ANE.0000000000003574","article-title":"Incidence and epidemiology of perioperative transfusion-related pulmonary complications in pediatric noncardiac surgical patients: a single-center, 5-year experience","volume":"127","author":"Thalji","year":"2018","journal-title":"Anesth Analg"},{"key":"B29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/trf.12249","article-title":"Transfusion-related lung injury in children: a case series and review of the literature","volume":"54","author":"Lieberman","year":"2014","journal-title":"Transfusion"},{"key":"B30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cll.2020.10.004","article-title":"Pediatric hemovigilance and adverse transfusion reactions","volume":"41","author":"Sostin","year":"2021","journal-title":"Clin Lab Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.alit.2022.07.006","article-title":"Control of immunity and allergy by steroid hormones","volume":"71","author":"Ikuta","year":"2022","journal-title":"Allergol Int"},{"key":"B32","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/bjh.18789","article-title":"Guideline on the investigation and management of acute transfusion reactions","volume":"201","author":"Soutar","year":"2023","journal-title":"Br J Haematol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/all.15032","article-title":"EAACI guidelines: anaphylaxis (2021 update)","volume":"77","author":"Muraro","year":"2022","journal-title":"Allergy"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.jaip.2019.11.013","article-title":"Prevalence of errors in anaphylaxis in kids (PEAK): a multicenter simulation-based study","volume":"8","author":"Maa","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.21037\/atm-22-4932","article-title":"Research progress on febrile non-hemolytic transfusion reaction: a narrative review","volume":"10","author":"Wang","year":"2022","journal-title":"Ann Transl Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.33160\/yam.2018.03.013","article-title":"Analysis of acute transfusion reactions and their occurrence times","volume":"61","author":"Hatayama","year":"2018","journal-title":"Yonago Acta Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"103152","DOI":"10.1016\/j.transci.2021.103152","article-title":"Frequency and clinical characteristics of allergic transfusion reactions in children","volume":"60","author":"Celik","year":"2021","journal-title":"Transfus Apher Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.jaci.2014.03.030","article-title":"Defining risk factors and presentations of allergic reactions to platelet transfusion","volume":"133","author":"Savage","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1111\/j.1537-2995.2010.03009.x","article-title":"Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes","volume":"51","author":"Savage","year":"2011","journal-title":"Transfusion"},{"key":"B40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.iac.2021.09.005","article-title":"Management of anaphylaxis","volume":"42","author":"Navalpakam","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"key":"B41","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/ped.14572","article-title":"Preventing adverse reactions in pediatric transfusions using washed platelet concentrate","volume":"63","author":"Yanagisawa","year":"2021","journal-title":"Pediatr Int"},{"key":"B42","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/j.1365-2141.2005.05670.x","article-title":"Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children","volume":"130","author":"Sanders","year":"2005","journal-title":"Br J Haematol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e578","DOI":"10.1097\/MPH.0000000000002630","article-title":"Do children with an allergic transfusion reaction require premedication for all blood products?","volume":"45","author":"Bahabri","year":"2023","journal-title":"J Pediatr Hematol Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1111\/trf.12597","article-title":"A comparison of adverse reaction rates for PAS C versus plasma platelet units","volume":"54","author":"Cohn","year":"2014","journal-title":"Transfusion"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1724454\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:03:47Z","timestamp":1775801027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1724454\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":44,"alternative-id":["10.3389\/fped.2026.1724454"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1724454","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"article-number":"1724454"}}